Aldehyde dehydrogenase 1 (ALDH1) positivity correlates with poor prognosis in cervical cancer

21Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objective: To analyse the associations between aldehyde dehydrogenase 1 (ALDH1) tumour immunopositivity and disease-free survival in cervical carcinoma. Methods: ALDH1 immunohistochemistry was performed on formalin-fixed, paraffin wax-embedded cervical tumour tissue samples obtained from hospital archives. Data regarding disease-free survival were obtained. Kaplan-Meier survival analyses and Cox proportional hazards regression models were performed. Results: Patients with ALDH1-positive tumours (n = 31) had significantly shorter disease-free survival than those with ALDH1-negative tumours (n = 167; 41.99 ± 0.90 vs 53.64 ± 2.67 months). ALDH1 positivity was associated with poor prognosis (relative risk 2.727; 95% confidence intervals 1.253, 5.914). Conclusions: ALDH1 positivity is associated with poor prognosis of cervical carcinoma, and may be an independent predictor of prognosis. © The Author(s) 2014.

Cite

CITATION STYLE

APA

Yao, T., Wu, Z., Liu, Y., Rao, Q., & Lin, Z. (2014). Aldehyde dehydrogenase 1 (ALDH1) positivity correlates with poor prognosis in cervical cancer. Journal of International Medical Research, 42(4), 1038–1042. https://doi.org/10.1177/0300060514527060

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free